omega-n-methylarginine has been researched along with fenretinide in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (fenretinide) | Trials (fenretinide) | Recent Studies (post-2010) (fenretinide) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 881 | 93 | 215 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Broemeling, LD; Ekmekcioglu, S; Grimm, EA; Simeone, AM; Tari, AM | 1 |
1 other study(ies) available for omega-n-methylarginine and fenretinide
Article | Year |
---|---|
A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Division; Enzyme Inhibitors; Fenretinide; Flow Cytometry; Humans; Immunohistochemistry; Interferon-gamma; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Tamoxifen; Tumor Cells, Cultured | 2002 |